HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Matthay Selected Research

Adrenergic beta-Agonists (beta-Adrenergic Agonists)

5/2001Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats.
1/2001Transepithelial sodium and water transport in the lung. Major player and novel therapeutic target in pulmonary edema.
10/2000Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats.
9/2000Alveolar epithelial barrier. Role in lung fluid balance in clinical lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A Matthay Research Topics

Disease

22Acute Lung Injury
01/2016 - 01/2000
12Lung Injury
12/2021 - 03/2000
12Pulmonary Edema
10/2014 - 06/2000
12Edema (Dropsy)
08/2007 - 06/2000
5Hypoxia (Hypoxemia)
01/2016 - 02/2000
4Inflammation (Inflammations)
10/2014 - 04/2000
4Pneumonia (Pneumonitis)
07/2012 - 02/2000
3Sepsis (Septicemia)
02/2009 - 03/2001
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2003 - 07/2001
3Shock
01/2002 - 09/2000
2Peritonitis
07/2012 - 06/2001
2Wounds and Injuries (Trauma)
04/2001 - 12/2000
2Pleural Effusion (Pleural Effusions)
12/2000 - 06/2000
2Critical Illness (Critically Ill)
02/2000 - 01/2000
1Viral Pneumonia
12/2021
1Primary Graft Dysfunction
01/2017
1Tachycardia (Tachyarrhythmias)
03/2014
1Brain Death (Brain Dead)
03/2014
1Left Ventricular Dysfunction
12/2012
1Hyperoxia
02/2009
1Ventilator-Induced Lung Injury
02/2008
1Surfactant Dysfunction
08/2007
1Reperfusion Injury
07/2006
1Hemorrhage
02/2005
1Disease Progression
11/2003
1Cystic Fibrosis (Mucoviscidosis)
07/2001
1Hemorrhagic Shock
05/2001
1End Stage Liver Disease
01/2001

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2000
5AlbuminsIBA
10/2014 - 05/2000
5CatecholaminesIBA
11/2002 - 09/2000
4Oxygen (Dioxygen)IBA
02/2009 - 02/2000
4Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
05/2001 - 09/2000
3Biomarkers (Surrogate Marker)IBA
01/2017 - 03/2000
3beta Adrenergic ReceptorsIBA
12/2012 - 05/2001
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2006 - 06/2000
2AcidsIBA
01/2016 - 06/2000
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
10/2014 - 11/2003
2IntegrinsIBA
07/2012 - 06/2001
2Interleukin-1beta (Interleukin 1 beta)IBA
02/2008 - 05/2001
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
02/2008 - 05/2001
2geldanamycinIBA
07/2006 - 01/2002
2pyrrolidine dithiocarbamic acidIBA
07/2006 - 05/2001
2Reactive Nitrogen SpeciesIBA
01/2002 - 05/2001
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2002 - 05/2000
2Terbutaline (Brethaire)FDA LinkGeneric
07/2001 - 05/2000
2denopamineIBA
07/2001 - 01/2001
2Amiloride (Midamor)FDA LinkGeneric
06/2001 - 05/2000
2NitrogenIBA
01/2001 - 05/2000
2ThioureaIBA
12/2000 - 06/2000
2Evans Blue (Blue, Evans)FDA Link
06/2000 - 05/2000
1Biological FactorsIBA
01/2017
1EndotoxinsIBA
01/2016
1SmokeIBA
10/2014
1Albuterol (Salbutamol)FDA LinkGeneric
03/2014
1Pharmaceutical PreparationsIBA
03/2014
1ThrombinFDA Link
02/2009
1AntithrombinsIBA
02/2009
1Plasminogen Activators (Plasminogen Activator)IBA
02/2009
1Protein CIBA
02/2009
1ThrombomodulinIBA
02/2009
1Receptor for Advanced Glycation End ProductsIBA
12/2008
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2008
1Interleukin-1 (Interleukin 1)IBA
02/2008
1FibrinIBA
08/2007
1PhosgeneIBA
08/2007
1CollagenIBA
08/2007
1Heat-Shock Proteins (Heat-Shock Protein)IBA
07/2006
1Adenosine Monophosphate (AMP)IBA
02/2005
1Surface-Active Agents (Surfactants)IBA
11/2003
1von Willebrand FactorIBA
12/2001
1AntigensIBA
12/2001
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2001
1trimethyloxamine (trimethylamine N-oxide)IBA
07/2001
1Bleomycin (Blenoxane)FDA LinkGeneric
06/2001
1Escherichia coli endotoxinIBA
06/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2001
1Transforming Growth Factor beta (TGF-beta)IBA
06/2001
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2001
1ColforsinIBA
05/2001
1Sulfasalazine (Azulfidine)FDA LinkGeneric
05/2001
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
05/2001
1NF-kappa B (NF-kB)IBA
05/2001
1Nitric Oxide Synthase (NO Synthase)IBA
05/2001
1Arginine (L-Arginine)FDA Link
04/2001
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
04/2001
1GTP Phosphohydrolases (GTPases)IBA
04/2001
1Bacterial Proteins (Bacterial Protein)IBA
04/2001
1AnticoagulantsIBA
03/2001
1NitritesIBA
01/2001
1Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
01/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2001
1Blood Proteins (Serum Proteins)IBA
01/2001

Therapy/Procedure

7Therapeutics
12/2021 - 01/2000
6Artificial Respiration (Mechanical Ventilation)
02/2008 - 01/2000
4Mechanical Ventilators (Ventilator)
11/2008 - 10/2001
2Lung Transplantation
01/2017 - 05/2014
2Transplantation
05/2014 - 12/2012
2Noninvasive Ventilation
06/2000 - 01/2000
1Liver Transplantation
01/2001